Author:
Choi Seung H.,Wright Jason B.,Gerber Scott A.,Cole Michael D.
Abstract
Rapid Myc protein turnover is critical for maintaining basal levels of Myc activity in normal cells and a prompt response to changing growth signals. We characterize a new Myc-interacting factor, TRPC4AP (transient receptor potential cation channel, subfamily C, member 4-associated protein)/TRUSS (tumor necrosis factor receptor-associated ubiquitous scaffolding and signaling protein), which is the receptor for a DDB1 (damage-specific DNA-binding protein 1)–CUL4 (Cullin 4) E3 ligase complex for selective Myc degradation through the proteasome. TRPC4AP/TRUSS binds specifically to the Myc C terminus and promotes its ubiquitination and destruction through the recognition of evolutionarily conserved domains in the Myc N terminus. TRPC4AP/TRUSS suppresses Myc-mediated transactivation and transformation in a dose-dependent manner. Finally, we found that TRPC4AP/TRUSS expression is strongly down-regulated in most cancer cell lines, leading to Myc protein stabilization. These studies identify a novel pathway targeting Myc degradation that is suppressed in cancer cells.
Publisher
Cold Spring Harbor Laboratory
Subject
Developmental Biology,Genetics
Reference30 articles.
1. A modest reduction in c-myc expression has minimal effects on cell growth and apoptosis but dramatically reduces susceptibility to Ras and Raf transformation;Cancer Res,2001
2. In vivo degradation of N-myc in neuroblastoma cells is mediated by the 26S proteasome
3. The c-Myc Transactivation Domain Is a Direct Modulator of Apoptotic versus Proliferative Signals
4. Prolonged N-myc protein half-life in a neuroblastoma cell line lacking N-myc amplification;Oncogene,1990
5. Mechanism of transcriptional activation by the Myc oncoproteins
Cited by
92 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献